Skip to main content
American Journal of Men's Health logoLink to American Journal of Men's Health
editorial
. 2019 Jun 19;13(3):1557988319859113. doi: 10.1177/1557988319859113

The Opioid Overdose Epidemic and the Urgent Need for Effective Public Health Interventions That Address Men Who Use Drugs Alone

Geoff Bardwell 1,2,, Thomas Kerr 1,2, Ryan McNeil 1,2
PMCID: PMC6587386  PMID: 31216926

North America is amid an overdose crisis that is showing no signs of slowing down. In 2017, there were 10.9 opioid-related deaths per 100,000 individuals in the United States (Ahmad, Rossen, Spencer, Warner, & Sutton, 2018). In Canada, data from the first half of 2018 show a rate of 11.2 opioid-related deaths per 100,000 individuals (Government of Canada, 2018) and as high as 31 deaths per 100,000 individuals in the province of British Columbia (BC Coroners Service, 2019). The public health response to the opioid overdose epidemic has been challenging, given the proliferation of illicit fentanyl and fentanyl-adulterated drugs across the continent (Ciccarone, 2017; Fairbairn, Coffin, & Walley, 2017). Given the reality of a poisoned illicit drug market, there has been a variety of public health interventions implemented in various settings to address the overdose crisis, including naloxone training and distribution (Bardwell, Fleming, Collins, Boyd, & McNeil, 2019; Sherman et al., 2009; Tobin, Clyde, Davey-Rothwell, & Latkin, 2018), drug checking programs (Bardwell & Kerr, 2018; Krieger et al., 2018; Peiper et al., 2019; Tupper, McCrae, Garber, Lysyshyn, & Wood, 2018), and supervised injection sites (Boyd et al., 2018; Kral & Davidson, 2017; Strike & Watson, 2019; Wallace, Pagan, & Pauly, 2019).

While the scale-up of these interventions has shown some promise in responding to overdoses in community settings (i.e., at the street level), there is an urgent need to address drug overdoses that occur in housing environments (e.g., emergency shelters, supportive housing, private market housing; Bardwell, Boyd, Kerr, & McNeil, 2018; Davidson et al., 2003). For example, a longitudinal study of opioid overdoses in New York City identified that 75% of overdose deaths occurred in a home (Siegler, Tuazon, Bradley O’Brien, & Paone, 2014). Similarly, in the Canadian context, the majority of opioid overdose deaths in British Columbia involve men who are using drugs alone indoors (BC Coroners Service, 2019). These findings suggest that targeted overdose response interventions in housing environments generally, and those for men specifically, should be key priorities. Unfortunately, there are very few housing-based interventions despite the clear and outstanding need (Bardwell, Collins, McNeil, & Boyd, 2017).

There is ample research on the ways in which gender role socialization (e.g., notions and expectations of manhood, masculinities) affects men’s health and well-being (Gough & Robertson, 2010). Masculinity has been defined as a social construct that places men at the top of the gender hierarchy, shapes norms and behaviors based on this hierarchy, and varies across space and time (Kimmel, Hearn, & Connel, 2005). Socially-constructed masculine characteristics include rationality, strength, dominance, risk-taking, machoism, and heroism. The effects of masculinity have been reported to undermine health service access and related outcomes. For example, studies have identified how health promotion programs lack a “manly appeal” and are in contrast to gendered norms and expectations of independence and self-reliance (Sharp et al., 2018). Research on pain has demonstrated that some men perceive the experience of pain as unmanly (Gough & Robertson, 2010). Men’s reluctance to disclose experiences of pain and suffering, and consequently delay seeking the required medical attention, are a result of gender socialization and can lead men to self-diagnose rather than seek professional care (Gough & Robertson, 2010). Additionally, research on health and safety for men in high-risk occupations has reported how notions of masculinity frame how risk is perceived, normalized, and accepted by men (Stergiou-Kita et al., 2015). These examples demonstrate some of the ways in which masculinity impacts the health outcomes of men specifically.

However, less is known about how masculinities affect drug use. A 1998 qualitative study of drug use and street survival on the United States–Mexican border investigates machismo and hypermasculinity among men who inject drugs. This study highlights how structural factors such as institutionalized racism and poverty influence machismo attitudes and behaviors among men and how social status is gained via violence and drug use (Quintero & Estrada, 1998). A more recent qualitative study on recreational drug use among men in Ireland investigates the gendered practices, expectations, and beliefs regarding drug use and how masculinity frames men’s practices. This study demonstrates how using drugs within drug user circles was associated with machoism and how drug use initiation was part of men’s socialization and belonging (Darcy, 2018). Though, the ways in which gender role socialization affects overdose risk and related public health interventions, in general, and using drugs alone, specifically, remain to be examined.

Public health communication strategies specific to the overdose crisis have largely consisted of messaging that targets individual drug use behaviors. These include warnings about fentanyl-contaminated street drugs and encouraging people who use drugs (PWUD) to moderate their use by starting with a small amount of drugs and to never use drugs alone (British Columbia Centre for Disease Control, 2015). However, research has been critical of the potential of such warnings to change individual drug use behaviors (Kerr, Small, Hyshka, Maher, & Shannon, 2013). Moreover, this type of public health messaging fails to consider and address the larger socio-structural contexts that create overdose risks for PWUD, including gender socialization. For example, is using smaller amounts of drugs considered less masculine? Does health promotion on drug use lack a manly appeal or is it antithetical to masculine attitudes regarding independence and self-reliance?

There is minimal research on the social and structural conditions that influence individuals (of all genders) to use drugs alone. Some research suggests that using alone is a way for PWUD to hide their use from others due to the stigma and shame associated with drug use (Bardwell, Boyd, Kerr, & McNeil, 2018; Rhodes et al., 2007). Other studies suggest that PWUD hide their use due to the criminalization of drugs and the heightened risks associated with using drugs in public, including intimidation and arrests from police (Small, Kerr, Charette, Schechter, & Spittal, 2006). Further, given that many PWUD live in poverty with minimal secure income, and given the cultural convention of sharing drugs when using in the presence of other PWUD, many individuals will use alone in order to derive as much as possible from their limited resources (Moore, 2004). These studies importantly illuminate contextual factors that frame using alone and associated risks and highlight the limitations of conventional overdose prevention messaging. Still, it remains unclear as to why the majority of those who have died of opioid overdoses while using alone are men.

Some research demonstrates that naloxone (i.e., a medication that blocks the effects of opiates) programs have been an effective response to overdose in some housing environments (Bardwell et al., 2019; Bardwell, Kerr, Boyd, & McNeil, 2018); however, naloxone is ineffective when individuals are using drugs alone, as it requires another person to administer it. Further, recent evidence has indicated that while many individuals receive naloxone kits and related training, most individuals do not carry naloxone on a regular basis (Tobin et al., 2018). Additionally, drug checking programs (i.e., technologies that allow individuals to identify the contents of their drugs) have been useful in some settings, as they have the potential to promote informed decisions and change in drug use behavior, such as using less than usual (Peiper et al., 2019). However, studies on drug checking are limited and it is not known how effective these interventions would be in housing environments, nor how gender would affect the use of these technologies. These demonstrate critical gaps in the public health response that warrant immediate attention.

Given the lack of research in this area, studies are urgently needed to understand the gendered social and structural conditions that lead men to use drugs alone, particularly during an overdose crisis, marked by a toxic illicit drug market. For example, how do gendered dynamics, attitudes, and beliefs impact men’s decisions not to carry naloxone or utilize drug checking services? Are there gendered dimensions that limit men from using life-saving services such as supervised injection sites and instead use drugs alone elsewhere? Do attitudes regarding manliness or the normalization and acceptance of risk lead men to use drugs alone? How can public health move beyond “don’t use alone” messaging toward more effective communications that target men specifically? Would men access safe supply (i.e., prescription opioids) housing-based interventions?

Data from the British Columbia Coroner’s Service continues to demonstrate that the majority of opioid overdose deaths are occurring indoors among men who use drugs alone. Given this growing evidence, public health authorities must prioritize targeted interventions for men who use drugs alone as they are the most at risk of overdose death. Additionally, to more effectively address the opioid overdose crisis, there is a critical need for in-depth ethnographic and qualitative research with the potential to unpack existing epidemiological findings and better understand the gendered social and structural conditions that create overdose risk for men, including how these intersect with other axis of inequality such as race and class. Without such an understanding, too many men will continue to be lost to preventable overdose death.

Footnotes

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Geoff Bardwell is supported by a Mitacs Elevate Postdoctoral Fellowship from Mitacs Canada. Ryan McNeil is supported by a Canadian Institutes for Health Research (CIHR) New Investigator Award and a Michael Smith Foundation for Health Research Scholar Award. Thomas Kerr is supported by a CIHR Foundation Grant (20R74326). This research was supported by the US National Institutes of Health (R01DA044181).

ORCID iD: Geoff Bardwell Inline graphic https://orcid.org/0000-0003-3368-7681

References

  1. Ahmad F., Rossen L., Spencer M., Warner M., Sutton P. (2018). Provisional drug overdose death counts. United States: Retrieved from https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm
  2. Bardwell G., Boyd J., Kerr T., McNeil R. (2018). Negotiating space & drug use in emergency shelters with peer witness injection programs within the context of an overdose crisis: A qualitative study. Health & Place, 53, 86–93. doi: 10.1016/j.healthplace.2018.07.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bardwell G., Collins A. B., McNeil R., Boyd J. (2017). Housing and overdose: An opportunity for the scale-up of overdose prevention interventions? Harm Reduction Journal, 14(1), 77. doi: 10.1186/s12954-017-0203-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bardwell G., Fleming T., Collins A. B., Boyd J., McNeil R. (2019). Addressing Intersecting housing and overdose crises in Vancouver, Canada: Opportunities and challenges from a tenant-led overdose response intervention in single room occupancy hotels. Journal of Urban Health, 96(1), 12–20. doi: 10.1007/s11524-018-0294-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bardwell G., Kerr T. (2018). Drug checking: A potential solution to the opioid overdose epidemic? Substance Abuse Treatment, Prevention, and Policy, 13(1), 20. doi: 10.1186/s13011-018-0156-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bardwell G., Kerr T., Boyd J., McNeil R. (2018). Characterizing peer roles in an overdose crisis: Preferences for peer workers in overdose response programs in emergency shelters. Drug & Alcohol Dependence, 190, 6–8. doi: 10.1016/j.drugalcdep.2018.05.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. BC Coroners Service. (2019). Illicit drug overdose deaths in BC: January 1, 2008 - December 31, 2018. British Columbia; Retrieved from https://www2.gov.bc.ca/assets/gov/birth-adoption-death-marriage-and-divorce/deaths/coroners-service/statistical/illicit-drug.pdf [Google Scholar]
  8. Boyd J., Collins A. B., Mayer S., Maher L., Kerr T., McNeil R. (2018). Gendered violence and overdose prevention sites: A rapid ethnographic study during an overdose epidemic in Vancouver, Canada. Addiction, 113(12), 2261–2270. doi: 10.1111/add.14417 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. British Columbia Centre for Disease Control. (2015). Fentanyl campaign launches to raise awareness about the dangers of the drug. Retrieved from http://www.bccdc.ca/about/news-stories/news-releases/2015/fentanyl-campaign-launches-to-raise-awareness-about-the-dangers-of-the-drug
  10. Ciccarone D. (2017). Fentanyl in the US heroin supply: A rapidly changing risk environment. International Journal of Drug Policy, 46, 107–111. doi: 10.1016/j.drugpo.2017.06.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Darcy C. (2018). Making the invisible visible: Masculinities and men’s illicit recreational drug use. Irish Journal of Sociology, 26(1), 5–24. doi: 10.1177/0791603517735772 [DOI] [Google Scholar]
  12. Davidson P. J., McLean R. L., Kral A. H., Gleghorn A. A., Edlin B. R., Moss A. R. (2003). Fatal heroin-related overdose in San Francisco, 1997–2000: A case for targeted intervention. Journal of Urban Health, 80(2), 261–273. doi: 10.1093/jurban/jtg029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fairbairn N., Coffin P. O., Walley A. Y. (2017). Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic. International Journal of Drug Policy, 46, 172–179. doi: 10.1016/j.drugpo.2017.06.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gough B., Robertson S. (Eds.). (2010). Men, masculinities and health: Critical perspectives. Basingstoke: Palgrave Macmillan. [Google Scholar]
  15. Government of Canada. (2018). Overview of national data on opioid-related harms and deaths. Retrieved from https://www.canada.ca/en/health-canada/services/substance-use/problematic-prescription-drug-use/opioids/data-surveillance-research/harms-deaths.html
  16. Kerr T., Small W., Hyshka E., Maher L., Shannon K. (2013). ‘It’s more about the heroin’: Injection drug users’ response to an overdose warning campaign in a Canadian setting. Addiction, 108(7), 1270–1276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kimmel M., Hearn J., Connel R. (Eds.). (2005). Handbook of studies on men and masculinities. Thousand Oaks, CA: Sage Publications. [Google Scholar]
  18. Kral A. H., Davidson P. J. (2017). Addressing the nation’s opioid epidemic: Lessons from an unsanctioned supervised injection site in the U.S. American Journal of Preventive Medicine, 53(6), 919–922. doi: 10.1016/j.amepre.2017.06.010 [DOI] [PubMed] [Google Scholar]
  19. Krieger M. S., Goedel W. C., Buxton J. A., Lysyshyn M., Bernstein E., Sherman S. G., . . . Marshall B. D. L. (2018). Use of rapid fentanyl test strips among young adults who use drugs. International Journal of Drug Policy, 61, 52–58. doi: 10.1016/j.drugpo.2018.09.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Moore D. (2004). Governing street-based injecting drug users: A critique of heroin overdose prevention in Australia. Social Science & Medicine, 59(7), 1547–1557. doi: 10.1016/j.socscimed.2004.01.029 [DOI] [PubMed] [Google Scholar]
  21. Peiper N. C., Clarke S. D., Vincent L. B., Ciccarone D., Kral A. H., Zibbell J. E. (2019). Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States. International Journal of Drug Policy, 63, 122–128. doi: 10.1016/j.drugpo.2018.08.007 [DOI] [PubMed] [Google Scholar]
  22. Quintero G. A., Estrada A. L. (1998). Cultural models of masculinity and drug use: “Machismo,” heroin, and street survival on the U.S.-Mexico border. Contemporary Drug Problems, 25(1), 147–168. doi: 10.1177/009145099802500107 [DOI] [Google Scholar]
  23. Rhodes T., Watts L., Davies S., Martin A., Smith J., Clark D., . . . Lyons M. (2007). Risk, shame and the public injector: A qualitative study of drug injecting in South Wales. Social Science & Medicine, 65(3), 572–585. doi: 10.1016/j.socscimed.2007.03.033 [DOI] [PubMed] [Google Scholar]
  24. Sharp P., Bottorff J. L., Hunt K., Oliffe J. L., Johnson S. T., Dudley L., Caperchione C. M. (2018). Men’s perspectives of a gender-sensitized health promotion program targeting healthy eating, active living, and social connectedness. American Journal of Men’s Health, 12(6), 2157–2166. doi: 10.1177/1557988318799159 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sherman S. G., Gann D. S., Tobin K. E., Latkin C. A., Welsh C., Bielenson P. (2009). “The life they save may be mine”: Diffusion of overdose prevention information from a city sponsored programme. International Journal of Drug Policy, 20(2), 137–142. doi: 10.1016/j.drugpo.2008.02.004 [DOI] [PubMed] [Google Scholar]
  26. Siegler A., Tuazon E., Bradley O’Brien D., Paone D. (2014). Unintentional opioid overdose deaths in New York City, 2005–2010: A place-based approach to reduce risk. International Journal of Drug Policy, 25(3), 569–574. doi: 10.1016/j.drugpo.2013.10.015 [DOI] [PubMed] [Google Scholar]
  27. Small W., Kerr T., Charette J., Schechter M. T., Spittal P. M. (2006). Impacts of intensified police activity on injection drug users: Evidence from an ethnographic investigation. International Journal of Drug Policy, 17(2), 85–95. doi: 10.1016/j.drugpo.2005.12.005 [DOI] [Google Scholar]
  28. Stergiou-Kita M., Mansfield E., Bezo R., Colantonio A., Garritano E., Lafrance M., . . . Travers K. (2015). Danger zone: Men, masculinity and occupational health and safety in high risk occupations. Safety Science, 80, 213–220. doi: 10.1016/j.ssci.2015.07.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Strike C., Watson T. M. (2019). Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada. International Journal of Drug Policy. doi: 10.1016/j.drugpo.2019.02.005 [DOI] [PubMed] [Google Scholar]
  30. Tobin K., Clyde C., Davey-Rothwell M., Latkin C. (2018). Awareness and access to naloxone necessary but not sufficient: Examining gaps in the naloxone cascade. International Journal of Drug Policy, 59, 94–97. doi: 10.1016/j.drugpo.2018.07.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Tupper K. W., McCrae K., Garber I., Lysyshyn M., Wood E. (2018). Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting. Drug & Alcohol Dependence, 190, 242–245. doi: 10.1016/j.drugalcdep.2018.06.020 [DOI] [PubMed] [Google Scholar]
  32. Wallace B., Pagan F., Pauly B. B. (2019). The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency. International Journal of Drug Policy, 66, 64–72. doi: 10.1016/j.drugpo.2019.01.017 [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Men's Health are provided here courtesy of SAGE Publications

RESOURCES